Raphael Pharmaceutical (RAPH) Receivables - Other (2023)

Raphael Pharmaceutical (RAPH) reported Receivables - Other of $100000.0 for Q4 2023.

Raphael Pharmaceutical (RAPH) Receivables - Other (2023) Analysis & Trends

Raphael Pharmaceutical (RAPH) has 1 years of Receivables - Other data on file, last reported at $100000.0 in Q4 2023.

For the quarter ending Q4 2023, Receivables - Other changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Dec 2023 stood at $100000.0 (changed N/A YoY), and the FY2023 full-year result was $100000.0, changed N/A from the prior year.
Receivables - Other held at $100000.0 in Q4 2023.
In the past five years, Receivables - Other ranged from a high of $100000.0 in Q4 2023 to a low of $100000.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Raphael Pharmaceutical	27.37 Mn	27.33 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	100,000.00
Dec 31, 2023	100,000.00